Stay updated on CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial
Sign up to get notified when there's something new on the CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial page.

Latest updates to the CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page adds a Locations section listing study sites in California, New Jersey, Pennsylvania, and Rio Grande do Sul, Brazil, and records revision v3.3.3. The previous location blocks are removed or reorganized.SummaryDifference0.5%

- Check23 days agoNo Change Detected
- Check44 days agoChange DetectedAdded Revision: v3.3.2 and removed Revision: v3.2.0 on the page. This appears to be a minor versioning update that does not change study content or functionality.SummaryDifference0.1%

- Check52 days agoChange DetectedThe government funding lapse notice was removed from the page. The study details and related content remain unchanged; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check73 days agoChange DetectedThe update looks like a routine record refresh with no changes to core study elements (eligibility criteria, outcomes, or treatment details). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check95 days agoChange DetectedAdded a prominent government funding notice and a current operating status note, plus a version update to v3.2.0; removed the previous v3.1.0 tag.SummaryDifference3%

- Check102 days agoChange DetectedContent updates expand SIDS-related topics and related pathological terms, and update the revision version from v3.0.2 to v3.1.0.SummaryDifference0.8%

Stay in the know with updates to CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial page.